Fabrinet
XBER:FAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fabrinet
XBER:FAN
|
KY |
|
V
|
Verrica Pharmaceuticals Inc
F:1NE
|
US |
|
D
|
DaVita Inc
XBER:TRL
|
US |
|
ESR-REIT
OTC:CGIUF
|
SG |
|
Vivoryon Therapeutics NV
F:05Y
|
DE |
|
C
|
Consolidated Edison Inc
F:EDC
|
US |
Wall St Price Targets
FAN Price Targets Summary
Fabrinet
According to Wall Street analysts, the average 1-year price target for FAN is 432.2 EUR with a low forecast of 291.35 EUR and a high forecast of 569.59 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FAN's stock price target?
Price Target
432.2
EUR
According to Wall Street analysts, the average 1-year price target for FAN is 432.2 EUR with a low forecast of 291.35 EUR and a high forecast of 569.59 EUR.
What is the Revenue forecast for Fabrinet?
Projected CAGR
25%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 25%.
What is the Operating Income forecast for Fabrinet?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 3 years is 31%.
What is the Net Income forecast for Fabrinet?
Projected CAGR
31%
The compound annual growth rate for Net Income over the next 3 years is 31%.
